In this week’s episode of #AskDrDurie Dr. Brian G.M. Durie discusses the importance of the 17p deletion chromosome abnormality when remission has been achieved.

Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.